Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

NCT04478071 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

448

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome
Coronavirus Infection

Interventions

DRUG: vadadustat
DRUG: placebo

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]
[object Object]